A. Muller, B. Homey, H. Soto, N. Ge, D. Catron et al., Involvement of chemokine receptors in breast cancer metastasis, Nature, vol.45, issue.6824, pp.50-56, 2001.
DOI : 10.1083/jcb.98.4.1265

S. Barbero, R. Bonavia, A. Bajetto, C. Porcile, P. Pirani et al., Stromal cell-derived factor 1? stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt, Cancer Res, vol.63, 1969.

R. Strieter, S. Kunkel, V. Elner, C. Martonyi, A. Koch et al., Interleukin-8. A corneal factor that induces neovascularization, Am J Pathol, vol.141, pp.1279-1284, 1992.

F. Balkwill and A. Mantovani, Inflammation and cancer: back to Virchow?, The Lancet, vol.357, issue.9255, pp.539-545, 2001.
DOI : 10.1016/S0140-6736(00)04046-0

C. Lewis and J. Pollard, Distinct Role of Macrophages in Different Tumor Microenvironments, Cancer Research, vol.66, issue.2, pp.605-612, 2006.
DOI : 10.1158/0008-5472.CAN-05-4005

A. Loercher, M. Nash, J. Kavanagh, C. Platsoucas, and R. Freedman, Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells, J Immunol, vol.163, pp.6251-6260, 1999.

A. Mantovani, P. Allavena, and A. Sica, Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression, 2004.

R. Leek and A. Harris, Tumor-associated macrophages in breast cancer, Journal of Mammary Gland Biology and Neoplasia, vol.7, issue.2, pp.177-189, 2002.
DOI : 10.1023/A:1020304003704

E. Lin, A. Nguyen, R. Russell, and J. Pollard, Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy, The Journal of Experimental Medicine, vol.112, issue.6, pp.727-740, 2001.
DOI : 10.1038/sj.onc.1201869

T. Kitamura, K. Kometani, H. Hashida, A. Matsunaga, H. Miyoshi et al., SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion, Nature Genetics, vol.51, issue.4, pp.467-475, 2007.
DOI : 10.1177/002215540305100613

T. Kitamura, T. Fujishita, P. Loetscher, L. Revesz, H. Hashida et al., Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model, Proceedings of the National Academy of Sciences, vol.105, issue.36, pp.13063-13068, 2010.
DOI : 10.1073/pnas.0800041105

X. Yang, P. Lu, C. Fujii, Y. Nakamoto, J. Gao et al., Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression, International Journal of Cancer, vol.53, issue.8, pp.1869-1876, 2006.
DOI : 10.1016/S0092-8674(02)00754-7

C. Combadiere, S. Potteaux, M. Rodero, T. Simon, A. Pezard et al., Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice, Circulation, vol.117, issue.13, pp.1649-1657, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.745091

H. Van-deventer, O. Connor, W. Jr, W. Brickey, R. Aris et al., C-C Chemokine Receptor 5 on Stromal Cells Promotes Pulmonary Metastasis, Cancer Research, vol.65, issue.8, pp.3374-3379, 2005.
DOI : 10.1158/0008-5472.CAN-04-2616

C. Bordignon, C. Carlo-stella, M. Colombo, D. Vincentiis, A. Lanata et al., Cell therapy: achievements and perspectives, Haematologica, vol.84, pp.1110-1149, 1999.

G. Lazennec and R. A. , Chemokines and chemokine receptors: new insights into cancer-related inflammation, Trends in Molecular Medicine, vol.16, issue.3, pp.133-144, 2010.
DOI : 10.1016/j.molmed.2010.01.003
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840699

M. Rodero, Y. Marie, M. Coudert, E. Blondet, K. Mokhtari et al., Gene Is Associated With Survival in Patients With Glioblastoma, Journal of Clinical Oncology, vol.26, issue.36, pp.5957-5964, 2008.
DOI : 10.1200/JCO.2008.17.2833

M. Rodero, P. Rodero, V. Descamps, C. Lebbe, P. Wolkenstein et al., Melanoma susceptibility and progression: Association study between polymorphisms of the chemokine (CCL2) and chemokine receptors (CX3CR1, CCR5), Journal of Dermatological Science, vol.46, issue.1, pp.72-76, 2007.
DOI : 10.1016/j.jdermsci.2006.11.007

C. Wang, B. Sun, Y. Tang, H. Zhuang, and W. Cao, CCR1 knockdown suppresses human non-small cell lung cancer cell invasion, Journal of Cancer Research and Clinical Oncology, vol.12, issue.5, pp.695-701, 2009.
DOI : 10.1016/S0002-9440(10)63921-1

X. Wu, J. Fan, X. Wang, J. Zhou, S. Qiu et al., Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion, Biochemical and Biophysical Research Communications, vol.355, issue.4, pp.866-871, 2007.
DOI : 10.1016/j.bbrc.2007.01.199

E. Menu, D. Leenheer, E. De-raeve, H. Coulton, L. Imanishi et al., Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model, Clinical & Experimental Metastasis, vol.33, issue.5-6, pp.291-300, 2006.
DOI : 10.1038/bjc.1997.409

P. Lu, Y. Nakamoto, Y. Nemoto-sasaki, C. Fujii, H. Wang et al., Potential Interaction between CCR1 and Its Ligand, CCL3, Induced by Endogenously Produced Interleukin-1 in Human Hepatomas, The American Journal of Pathology, vol.162, issue.4, pp.1249-1258, 2003.
DOI : 10.1016/S0002-9440(10)63921-1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851222

F. Geissmann, S. Jung, and D. Littman, Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties, Immunity, vol.19, issue.1, pp.71-82, 2003.
DOI : 10.1016/S1074-7613(03)00174-2

F. Tacke, D. Alvarez, T. Kaplan, C. Jakubzick, R. Spanbroek et al., Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques, Journal of Clinical Investigation, vol.117, issue.1, pp.185-194, 2007.
DOI : 10.1172/JCI28549
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716202

N. Iida, Y. Nakamoto, T. Baba, H. Nakagawa, E. Mizukoshi et al., Antitumor Effect after Radiofrequency Ablation of Murine Hepatoma Is Augmented by an Active Variant of CC Chemokine Ligand 3/Macrophage Inflammatory Protein-1??, Cancer Research, vol.70, issue.16, pp.6556-6565, 2010.
DOI : 10.1158/0008-5472.CAN-10-0096

A. Orimo, P. Gupta, D. Sgroi, F. Arenzana-seisdedos, T. Delaunay et al., Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion, Cell, vol.121, issue.3, pp.335-348, 2005.
DOI : 10.1016/j.cell.2005.02.034
URL : http://doi.org/10.1016/j.cell.2005.02.034

F. Vizoso, L. Gonzalez, M. Corte, J. Rodriguez, J. Vazquez et al., Study of matrix metalloproteinases and their inhibitors in breast cancer, British Journal of Cancer, vol.103, issue.6, pp.903-911, 2007.
DOI : 10.1677/erc.1.00719

R. Thomas, D. Pietrzak, M. Scicchitano, H. Thomas, D. Mcfarland et al., Detection and characterization of circulating endothelial progenitor cells in normal rat blood, Journal of Pharmacological and Toxicological Methods, vol.60, issue.3, pp.263-274, 2009.
DOI : 10.1016/j.vascn.2009.06.002

J. Hwang, K. Son, C. Kim, J. Ko, D. Na et al., Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis, Cytokine, vol.30, issue.5, pp.254-263, 2005.
DOI : 10.1016/j.cyto.2005.01.018

N. Suffee, H. Hlawaty, A. Meddahi-pelle, L. Maillard, L. Louedec et al., RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans, Angiogenesis, vol.276, issue.25, pp.727-744, 2012.
DOI : 10.1074/jbc.M010867200

G. Brooke, H. Tong, J. Levesque, and K. Atkinson, Molecular Trafficking Mechanisms of Multipotent Mesenchymal Stem Cells Derived from Human Bone Marrow and Placenta, Stem Cells and Development, vol.17, issue.5, pp.929-940, 2008.
DOI : 10.1089/scd.2007.0156

J. Huang, Z. Zhang, J. Guo, A. Ni, A. Deb et al., Genetic Modification of Mesenchymal Stem Cells Overexpressing CCR1 Increases Cell Viability, Migration, Engraftment, and Capillary Density in the Injured Myocardium, Circulation Research, vol.106, issue.11, pp.1753-1762, 2010.
DOI : 10.1161/CIRCRESAHA.109.196030

C. Cochain, M. Rodero, J. Vilar, A. Recalde, A. Richart et al., Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization, Cardiovascular Research, vol.88, issue.1, pp.186-195, 2010.
DOI : 10.1093/cvr/cvq153